Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Int. arch. otorhinolaryngol. (Impr.) ; 19(4): 349-353, Oct.-Dec. 2015. ilus
Article in English | LILACS | ID: lil-768334

ABSTRACT

Introduction Laryngeal neurofibromas are extremely rare, accounting for only 0.03 to 0.1% of benign tumors of the larynx. Objectives To report the first case of massive neck plexiform neurofibroma with intralaryngeal (supraglottic) extension in a 5-year-old boy with neurofibromatosis type 1 and to describe its treatment. Resumed Report This massive plexiform neurofibroma was surgically removed, relieving its significant respiratory obstructive symptoms without recurrence to date. Conclusion Massive neck plexiform neurofibroma with supraglottic part was found in a child with neurofibromatosis type 1; it should be included in differential diagnosis of stridor and neck mass in children. It was diagnosed and removed in early in childhood without recurrence.(AU)


Subject(s)
Humans , Child, Preschool , Diagnosis, Differential , Neurofibroma, Plexiform/diagnosis , Neurofibromatosis 1/genetics , Diagnostic Imaging , Laryngoscopy , Magnetic Resonance Imaging
2.
Int. arch. otorhinolaryngol. (Impr.) ; 19(4): 298-301, Oct.-Dec. 2015. tab
Article in English | LILACS | ID: lil-768345

ABSTRACT

Introduction Otitis media with effusion (OME) continues to be an important pediatric clinical problem, and more studies are needed to decide the proper treatment for it. Objective To assess the efficacy of nasal steroids in the management of OME by comparing its results with that of oral steroid and that of nasal saline spray as placebo. Methods This study was carried on 60 patients with OME who were divided into three groups: in group 1, 20 patients received mometasone furoate spray, one puff in each nostril daily, for 3 months; in group 2, 20 patients received oral prednisolone, 5 mg three times per day for the first 3 weeks; in group 3, 20 patients received nasal saline spray, one puff in each nostril daily for 3 months. Results A highly significant difference between systemic or topical (nasal spray) steroid therapy and saline nasal spray was detected (p < 0.001), and the difference between systemic and topical steroid was nonsignificant (p > 0.05). Conclusion Nasal steroid spray can be used as an effective treatment for OME, giving a significant result similar to systemic steroid. Further studies are needed to investigate its use for longer duration and in recurrent cases.(AU)


Subject(s)
Humans , Male , Female , Child , Adolescent , Acoustic Impedance Tests , Otitis Media with Effusion/therapy , Steroids , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL